Inhibitor Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments
Inhibitor Therapeutics, Inc. (INTI) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments · last filed 2026-03-26
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for the quarter ending 2025-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for the quarter ending 2025-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for the quarter ending 2024-12-31 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for the quarter ending 2024-09-30 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2025 was $0.00.
- Inhibitor Therapeutics, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend payments for fiscal 2024 was $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-13 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $0.00 derived: sum of 2 quarters · filed 2026-03-26 | $0.00 derived: sum of 3 quarters · filed 2026-03-26 | $0.00 10-K · filed 2026-03-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-14 |